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Abstract
Aim: To assess preliminarily the potential benefits of the use of the platelet-rich fibrin (PRF) in
modern endodontic surgical procedures in terms of radiographic healing acceleration and
postoperative discomfort reduction.
Methodology: Eleven patients with chronic apical periodontitis were randomly assigned to either
the PRF (n = 7) or the control group (n = 4). Postoperative swelling and pain were assessed with a
questionnaire. Radiographic healing was scored according to Molven’s scale up to a period of one
year. Data were statistically analyzed with non-parametric tests.
Results: In the PRF group the patients experienced less pain in the 2—6 h postoperatively as well as
oedema, which never exceeded the moderate intraoral swelling. Radiographic healing was detecta-
ble earlier in the PRF group, with the majority of cases scored as complete healing after 2—3 months.
Conclusions: The adjunctive use of PRF might promote the acceleration of the radiographic healing
and reduce the postoperative discomfort.
 2015 Societa` Italiana di Endodonzia. Production and hosting by Elsevier B.V. All rights reserved.
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Introduction
Untreated pulp tissue necrosis may lead to periapical period-
ontitis, which represents a response of the bone around the
apex to restrain the local infective offence. Periapical heal-
ing can be achieved by root canal treatment, whose purpose
is to remove bacteria and remnants of infected tissue by
shaping, cleaning and filling with an inert material the entire
root canal system.1 The main cause of unsuccessful periapical
healing after primary endodontic therapy is the persistence
of bacteria and infected tissue in the endodontic space2 even
after orthograde endodontic treatment and retreatment; in
such cases, the last resort to maintain the tooth is repre-
sented by apical surgery.3 In the choice between orthograde
re-treatment and surgical approach, the latter has to be
preferred when the root canal filling is adequate, but symp-
toms are persisting, when re-treatment involves high risk
procedures or long posts are present in the root canal.4
Improvement in technical instruments and in surgical
techniques might enhance the outcome of endodontic sur-
gery.5 In fact, the employment of microsurgical techniques
and modern obturation materials raised the success rates
after root-end resection and retrograde filling to about 80—
90%.6,7 In order to induce bone regeneration and soft tissues
healing after oral surgery, the local application of hormones,
grow factors and plasma derivates has been advocated.8
Platelet-rich plasma (PRP), bone morphogenic proteins
(BMPs), platelet-derived growth factor (PDGF), parathyroid
hormone (PTH), and enamel matrix proteins (EMD) have been
locally applied to promote the healing potential of the
surgical site.8 Nevertheless, the effectiveness of their appli-
cation in endodontic surgery is still questionable and
the advantages they provide to both surgeon and patient
have been reported to be moderate and remain still
controversial.9—14
It has been advocated that Platelet-rich Fibrin (PRF) can
be considered a healing biomaterial because it is constituted
by a fibrin network in which platelets, leukocytes, cytokines
and stem cells are enmeshed.15 Moreover, the platelets in the
PRF network are capable of slowly releasing platelet-derived
growth factor (PDGF) and insulin-like growth factor
(IGF),16,17 even up to one week.18 The osteogenic potential
of these molecules has been already demonstrated.19,20 PRF
can be thought as a grow factor reservoir that can be
employed without exposing the patient to any immunogeni-
city or infection risk,21 because it is entirely composed of
nothing but the patient’s blood. The application of such a
specific biomaterial to endodontic surgery has already been
described in some recent case reports22—24 and a randomized
clinical trial in the specifical field of the treatment of api-
comarginal defects.25
Considering that the teeth undergoing apical surgery have
less predictable prognosis and even a single tooth can be
strategic in the whole oral prosthetic rehabilitation, the pos-
sibility of accelerating the bone regeneration in periapical
surgical defects might be of great interest to the clinician, in
order to proceed sooner with the permanent rehabilitation.
The aim of the present one-year follow-up pilot study is to
evaluate the radiographic healing and the postoperative
discomfort in patients undergoing apical surgery, either by
leaving the apical surgical cavity empty or by filling it with
the PRF gel. The null hypotheses were that periapical surgical
defects filled with the PRF gel require the same healing time
of sites treated by conventional surgical techniques and that
the patients experienced the same postoperative discomfort
with or without PRF application.
Materials and methods
Patient selection
In this study 11 patients underwent endodontic surgery for
the treatment of refractory periapical periodontitis. The
whole experimentation was conducted in accordance with
the declaration of Helsinki of 1983. The patients involved
were fully informed about the intent and the design of the
study and they were asked to give their approval by signing a
written consent.
Patients with severe systemic disorders (i.e. non-con-
trolled diabetes, immunologic diseases, malignant neoplastic
processes), thrombocytopenia or insufficient compliance
were excluded from the present study. For inclusion of
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Riassunto
Obiettivi: Valutare preliminarmente i potenziali benefici dell’uso del platelet-rich fibrin (PRF)
nella moderna endodonzia chirurgica in termini di accelerazione della guarigione radiografica e
riduzione del discomfort postoperatorio.
Materiali e metodi: Undici pazienti con paradentite periapicale cronica sono stati assegnati
casualmente al gruppo PRF (n = 7) o al gruppo controllo (n = 4). Gonfiore e dolore postoperatori
sono stati valutati con un questionario. Nell’arco di un anno di osservazione e` stato assegnato un
punteggio alla guarigione radiografica secondo la scala di Molven. I dati sono stati analizzati
statisticamente con test non parametrici.
Risultati: I pazienti del gruppo PRF hanno provato meno dolore nelle 2—6 ore postoperatorie e
sviluppato minor edema, che era sempre limitato e intraorale. Nel gruppo PRF la guarigione
radiografica era individuabile precocemente, con la maggioranza dei casi classificata come
guarigione completa dopo 2—3 mesi.
Conclusioni: L’uso aggiuntivo del PRF sembra promuovere l’accelerazione della guarigione
radiografica e ridurre il discomfort postoperatorio.
 2015 Societa` Italiana di Endodonzia. Production and hosting by Elsevier B.V. Tutti i diritti
riservati.
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patients, we selected adult individuals presenting a tooth
with persisting periapical radiolucency, the presence of fis-
tula and symptoms after orthograde retreatment and a high
risk of jeopardize the root integrity by orthograde approach.
Each patient was randomly assigned to the control group
(n = 4) or PRF test group (n = 7) by simple computerized
randomization procedures. Detailed information about the
patients involved in the study are reported in Table 1.
Surgical procedure
A single surgeon performed all surgical interventions under
operating microscope magnification. Lidocaine with epi-
nephrine 1:50,000 was employed as local anaesthetic.
Twenty minutes were waited for the vasoactive agent to
constrict the local blood vessels in order to achieve optimal
haemostasis.3 Surgical access to the apical area of the
involved tooth was obtained via a full-thickness muco-gingi-
val flap with vertical releasing incisions. The bone around the
root apex was removed with a round bur mounted on a low-
speed handpiece under constant water irrigation. All gran-
ulomatous tissue was removed by manual curettage. Ferric
sulphate (Astringedent, Ultradent, South Jordan, UT, USA)
was used as haemostatic agent. The root was sectioned 3 mm
from the anatomical apex. The root-end cavity was per-
formed by using ultrasonic tips (KiS, Spartan Obtura, Fenton,
MI, USA), dried with sterile paper points (Inline, BM Dentale,
Turin, Italy) and filled with SuperEba (Regular setting powder,
Bosworth, Skokie, IL, USA). After the cement setting, the
apical surface of the resected root was dyed with methylene
blu and a surgical mirror was employed to verify the absence
of visible marginal defects. At the end of root-end filling
procedure the surgical site was abundantly flushed with
saline to remove blood clots and ferric sulphate residuals.
In the four patients of the control group, the bone defect was
not filled and the flap was sutured with 5  0 and 6  0
monofilament polypropylene. In the other 7 cases (PRF test
group), PRF gel was prepared as described below and applied
in the bone defect before repositioning and suturing the flap
(Fig. 1). Antibiotics were prescribed during the 6 days post-
operatively (1 g amoxicillin every 12 h). The choice to assume
analgesics was left to the patient. Sutures were removed
within 48—72 h from surgery.
PRF preparation
The PRF gel was obtained by following the protocol by
Choukroun et al.26 This consisted of collecting a small amount
Table 1 Patients involved in the study.
Group Subject Gender Age Tooth
Control group C1 F 45 1.3
C2 M 72 4.3
C3 F 37 1.5
C4 M 60 2.3
PRF test group T1 F 45 2.5
T2 M 43 1.5
T3 F 44 1.1
T4 F 47 1.2
T5 M 28 3.6
T6 M 42 3.7
T7 F 52 3.2
Figure 1 Phases of the PRF gel application: (A) check of the proper seal of the retrograde filling with a surgical mirror; (B) appearance
of the periapical bony defect; (C) positioning of the PRF gel in the bony defect with forceps; (D) adaptation of the gel to the defect after
compression with a gauze.
Application of platelet-rich fibrin in endodontic surgery 53
of the patient’s blood (10—40 mL in the case of our study) at
the needed moment of the surgical operation into dried
monovettes without anticoagulant agent (Vacuette, Greiner
Bio-One, Kremsmu¨nster, Austria). The collected blood was
immediately centrifuged for 10 min at 2,500 rpm. The pro-
duced clot was extracted from the container by using thin
sterile forceps and entirely employed, without depriving it of
the red thrombus.
Radiographic centering and examination
Customized filmholders and digital X-ray system (Vistascan
Dental Perio, Du¨rr Dental AG, Bietigheim, Germany) were
used throughout the study with a paralleling technique;27 the
X-ray device (2200 Intraoral X-Ray System, Kodak Dental
Systems, Rochester, NY, USA) was set at 70 kVp, 10 mA,
and 0.20 s exposure time. Radiographs were taken before
and after surgery, and at each follow-up visit; recalls were
planned at the 1st, 2nd, 3rd, 4th, 5th, 6th and 12th month
after surgery.
Two endodontists with 16 and 20 years of clinical experi-
ence extraneous to involved patients and study design were
calibrated.28,29 All radiographs were blindly examined twice
at interval of at least 30 days. Inter- and intraobserver
reproducibility was assessed by means of Kappa statistics.30
Each follow-up radiograph was assigned to the appropriate
category of the classification introduced by Molven
et al.:28,29 complete, incomplete, uncertain or unsatisfac-
tory healing (failure). Independently of the radiological peri-
apical condition, the presence of postoperative clinical
complications (e.g. sinus tract, apicomarginal communica-
tion, infection with tenderness to palpation or percussion)
reported at any time of the control visits was considered as
failure.
Pain and swelling assessment
The model for subjective data collection described by Pen-
narocha et al.31 was adopted. Each patient was asked to fill
out a questionnaire in which pain and swelling information
were recorded after 2, 6, and 12 h from the intervention, and
each day during the first 7 postoperative days. Pain was rated
as follows:
 0, absence of pain;
 1 (mild), recognizable but not discomforting pain that did
not require the assumption of analgesics;
 2 (moderate), discomforting but bearable pain that is
effectively relieved by analgesics, if assumed;
 3 (severe), pain that is difficult to bear.
The following scale was formulated to score the post-
operative swelling:
 0, absence of swelling;
 1, minor intraoral oedema localized to the surgical site;
 2, moderate extraoral swelling in the surgical zone;
 3, severe extraoral swelling beyond the treated area.
Statistical analysis
The Statistical Package for Social Sciences v. 15 (SPSS Inc.,
Chicago, IL, USA) was used for statistical analysis. Descriptive
statistics of the considered variables were performed. The
significance of the differences between the groups in terms
of periapical healing, pain and swelling scores was assessed
by means of a Mann-Whitney test. Since the present pilot
study was conducted on a restricted number of patients, a p
value less than 0.01 was regarded as statistically significant.
Results
The distribution of the periapical healing scores is showed in
Fig. 2. After the 1st radiographical recall, only one patient of
the PRF test group was classified as healed by the blinded
examiners and no significant differences were found between
the two groups. At the recalls after 2 and 3 months from the
surgical intervention, the PRF test group exhibited signifi-
cantly better periapical healing scores than the control
group. From that moment on, the periapical healing scores
of the control and test group were similar and no significant
difference was pointed out by the statistical analysis.
The graphs in Figs. 3 and 4 represent the changes in
postoperative pain and swelling during the time of observa-
tion hours and days after the surgical intervention. By con-
sidering both investigated parameters, average to low scores
were registered in the two groups with a trend of lower scores
associated with the application of PRF. More specifically, the
patients of the PRF test group felt less intense pain than the
control group during the first hours and days postoperatively,
Figure 2 Median values and interquartile ranges of periapical
healing scores after months (m) from the surgical intervention:
1, complete healing; 2, incomplete healing; 3, uncertain heal-
ing; 4, unsatisfactory healing. The asterisks mark statistically
significant differences between control and PRF experimental
groups at the specific time point ( p < 0.01).
Figure 3 Mean values and standard deviations of pain scores
after hours (h) and days (d) from the surgical intervention: 0,
absence of pain; 1, mild pain; 2, moderate pain; 3, severe pain.
The asterisks mark statistically significant differences between
control and PRF experimental groups at the specific time point
( p < 0.01).
54 D. Angerame et al.
with significantly lower scores after 2 and 6 h ( p < 0.01). As
to the swelling assessment, the maximum scores in both
groups were reached in the time period between the 12 h
and the second postoperative day. Starting from the third
postoperative day, the swelling slowly decreased in both
groups. The score in the PRF test group never exceeded
the moderate intraoral swelling.
Discussion
The present study evaluated the effects of the application of
PRF in endodontic surgery. Similar periapical healing scores
were assigned to the two groups at the first radiographic
control; true to form, one month was not enough to observe
mineralization changes with intraoral radiography, even in
the PRF test group. On the contrary, radiographic healing in
PRF test group appeared to be significantly improved after
two and three months from the surgical intervention. If
confirmed by studies involving a larger number of patients,
such an advantage is likely to arouse the interest of the
clinician, because the use of the PRF gel seems to accelerate
the healing process, which was detectable earlier. In many
clinical and operative situations the possibility to shorten the
follow-up period to only few months before proceeding with
the permanent rehabilitation would be a substantial asset.
Moreover, a general trend of reduced postoperative pain and
local swelling was noticed and must be considered in the
management of the patient’s overall comfort. In the first
hours postoperatively the majority of the patients belonging
to the test group experienced only mild pain (i.e. bearable
without assuming drugs); this means that their use of analge-
sics could be limited and has both clinical and economic
advantages. A clinical trial reported a beneficial effect of the
use of plasma rich in growth factors (PDGF) during endodontic
surgery in affecting postoperative symptoms and patient’s
quality of life after surgery.32 The authors described in detail
the procedure to obtain and apply this plasma concentrate to
the surgical site, which required several steps to be per-
formed, namely separating the plasmatic component in two
fractions, storing them, adding CaCl2 to enable clot forma-
tion and finally apply liquid and a clot of PRGF in three
steps.32 We chose to use PRF over PRGF because the former
has simpler procedures for both preparation and positioning
that allow to spare operative time potentially without com-
promising the clinical effectiveness.
One of most common indications to apical surgery is the
presence of an obstruction that does not allow the access to
the entire endodontic space and cannot be overcome. The
orthograde techniques for overstepping the obstruction
depend on the availability of specific instruments and above
all on the operator’s dexterity, so that they are hardly
standardizeable.4 Thus, it can be concluded that there are
no absolute indications to apical surgery,33 as they depend on
a host of factors. The benefits that PRF could provide in terms
of accelerated radiographic healing and limited postopera-
tive soreness might influence the therapeutic choice.
Preferring PRF over PRP in endodontic surgery depends on
several factors. Since in most cases the surgical bone defect
is likely to be small, PRF, differently from PRP, would be the
first choice because it requires the collection of very few
milliliters of blood. PRP is obtained from the patient’s own
blood to whom citrate dextrose solution A is added prior to
centrifuging.34,35 PRF was specifically created for oral and
maxillofacial surgery.26 The preparation of PRF requires
neither anticoagulant in the container nor addition of gelling
agent (i.e. bovine thrombin).36 The absence of anticoagulant
implies the need of fast transfer and immediate centrifuga-
tion of collected blood because fibrin polymerization is not
inhibited. During the first centrifugation phase, fibrinogen
concentrates in the upper part of the tube; thereafter,
circulating thrombin causes the slow transformation of fibri-
nogen into fibrin and the clot forms in the middle of the
tube.36 Red corpuscles sediment at tube’s bottom, whilst
acellular plasma supernatant collects at its top. The slow
gelling process distinguishes PRF by PRP and other plasma
derivates as it modifies the mechanical and biological char-
acteristics of the fibrin matrix.37 In fact, physiological throm-
bin concentration determines the organization of the fibrin
network in a biochemical architecture characterized by tri-
molecular or equilateral junctions between monomers.36
This three-dimensional structure allow the establishment
of a flexible, elastic and resistant PRF gel, in which cytokines
are retained and cellular migration is supported by the fibrin
network.38,39 Platelets are mainly entrapped in the clot at
the interface between the fibrin clot and its lower portion
(the red thrombus); thus, this portion of the plasma derivate
gains in clinical relevance because of the substances it
contains.38 PRF seems also capable of enmeshing glycosami-
noglycans,38 whose affinity for circulating platelet cytokines
can enhance the cell migration and the healing process.40
Cytokines are soluble molecules that play a relevant role in
healing and regeneration mechanisms in injured tissues;38,41
their capability of regulate inflammation and healing phe-
nomena consists of a multitude of molecular interactions that
has not been completely understood and described.39 The
biologic activity and clinical effectivess of the PRF gel ben-
efits from a partially known cytokines action. Our preliminary
results highlight a trend of lower postoperative discomfort
and accelerated bone healing in the patients who received
the PRF gel; these findings can be indicative of a attenuated
inflammatory response and enhanced healing of the surgical
site. The action of healing cytokines the PRF gel contains,
consists of interrupting the inflammation process or promot-
ing angiogenesis. The effects of interleukin 4 (IL-4) pro-
foundly depend on the cytokines environment.42 When
Figure 4 Mean values and standard deviations of swelling
scores after hours (h) and days (d) from the surgical intervention:
0, absence of swelling; 1, minor intraoral swelling; 2, moderate
extraoral swelling; 3, severe extraoral swelling. The asterisks
mark statistically significant differences between control and
PRF experimental groups at the specific time point ( p < 0.01).
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inflammatory processes are present, IL-4 acts as regulator by
inhibiting the IL-1b-mediated signal.43 The most powerful
agent for angiogenesis promotion is the vascular endothelial
growth factor (VEGF), which can control growth, migration
and differentiation of epithelial cells.44 PRF has been defined
an ‘‘immune organizing node’’ owing to its content in cyto-
kines with both pro- (IL-1b, IL-6, TNF-a) and anti-inflamma-
tory (IL-4) action, which was found to be superior than in
plasma concentrates.39
Although cytokines and cells enmeshed in PRF fibrin net-
work influence tissue healing, the molecular fibrin structure
seems to be the crucial characteristic of PRF.15 It is note-
worthy that fibrin employed in surgery as a single agent
cannot lead to sufficient bone regeneration.45 The complex
fibrin matrix of PRF can induce angiogenesis, because
endothelial cells can migrate and adhere to its articulate
structure in which they differentiate and proliferate.46 More-
over, one of the main angiogenesis soluble factors, the
platelet-derived growth factor (PDGF), binds to fibrin with
high affinity.47,48
Since PRF has been introduced in recent years, only a
small number of clinical studies on its efficacy have been
produced; nevertheless, hopeful results have been obtained
in different fields of oral surgery.21,49—51 Some clinical case
reports or series have been produced on the PRF application
to endodontic surgery, with the authors generally describing
reduced morbidity and discomfort for the patient and accel-
erated healing.22—24 Nevertheless, no effort is made in these
studies to standardize the surgical techniques or the pre-
operative conditions;23 moreover, some authors make use of
bone substitutes — e.g. hydroxyapatite or b-tricalcium phos-
phate (TCP)22,24 — which are likely to affect the reliability of
the radiographic assessment. On similar basic principles, also
a case report of a single periapical lesion treated with PRP
and allogenic graft (TCP) has been published.52 The authors
speculated that PRP could accelerate TCP resorption and
reported a subtotal replacement of the grafting material
with newly-formed bone 12 months after surgery. Since a
3-year follow up study on 146 teeth that underwent standard
periapical surgery reported that 66% of treated teeth could
be considered healed after 12 months,7 the use of PRP and
TCP as grafting material appears questionable at the
moment. Recently, a randomized controlled trial on the
surgical treatment of apicomarginal defects with PRF has
been published.25 However, endoperiodontal defects are
peculiar lesions, whose treatment is known to be particularly
arduous. The authors did not find significant benefit from the
use of PRF. Differently, the aim of the present study was to
assess the effect of PRF in endodontic lesions without period-
ontal communication, so it is probable that the gel can
express its beneficial effect in the absence of bacterial
interference from the marginal periodontum and other
non-controlled factors.
Similarly to the case of periodontal regenerative therapy,
bone grafting materials have been frequently employed in
endodontic surgery to promote bone regeneration and their
ability to induce new bone formation has been described
well.53 Notwithstanding, the risk of ankylosis after the use of
a grafting material in endodontic surgery has still to be
assessed because grafting materials might interfere with
the regeneration of the periodontal ligament. There are
no specific indications to bone grafting in periapical surgery
on account of their controversial ability to provide favour-
able healing and because of a lack of controlled clinical
trials.53 PRF is an autologous material that surmounts pro-
blems related to graft rejection, which might occur when the
source of the grafting material is allograft, alloplast or
xenograft.
Conclusions
The application of PRF gel in apical surgery showed promising
result in stimulating bone formation after 2 and 3 months
around periapical surgical defects and in reducing postopera-
tive discomfort. Further clinical studies are needed to con-
firm the findings of this pilot study.
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